VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: betty moyers who wrote (11265)	7/12/1998 11:12:00 AM
From: James Baker	Read Replies (1) of 23519

betty: 3. I do wonder how Vivus is going to target PCP's now. I thought their FDA approval required Uroligist perscription? Enlightenment please>>>>>>> Betty, Once the FDA approves a drug for US use ANY licensed doc may RX it if he/she so chooses to. Of course they are supposed to be familiar with the indications and contraindications and possible side effects to the medication use. Some docs don't want to bother with any thing that is not easy for them and the patient, even when safe and effective. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next